Phil's experience in organizational leadership makes him a positive, active team member. During law school, Phil authored multiple journal-length articles on intellectual property in the pharmaceutical space, including an award-winning article elaborating on unique IP litigation trends for biopharmaceutical companies that small-molecule manufacturers typically don't experience.